Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Race does not impact early mortality among patients with chronic HCV

Recent findings published in the Journal of Viral Hepatitis showed that race was a nonfactor in the early mortality of patients with hepatitis C virus infection. African-American patients with kidney disease and low albumin, however, were at greater risk for HCV-related mortality.

Published
13 June 2016
From
Healio
New HCV therapies unaffordable to health systems and individuals

The pricing of new treatments for hepatitis C virus (HCV) means they are unaffordable for many health systems in richer countries, according to an analysis published in

Published
09 June 2016
By
Michael Carter
People from occupied territories receive Georgian citizenship for free Hepatitis C treatment

More than 25 people from Georgia’s two Russian-occupied regions have asked for and received Georgian passports so they can benefit from the free Hepatitis C treatment program Georgia offers its citizens.

Published
07 June 2016
From
Agenda.ge
Ele Hamburger: Medicaid programs should be taking “a long hard look” at their drug policies under state and federal law

I think as a result of this case, Medicaid programs should be a taking a long hard look at whether their rationing criteria are justified under the state and federal law. When you have CMS saying it is not proper, and a federal judge saying it is inconsistent with federal Medicaid law, we hope you’re going to start to see other state programs eliminating those restrictions voluntarily.

Published
07 June 2016
From
State of Reform
Australia shows an alternative to rationing hepatitis C treatment

The Hepatitis C Trust has announced it is considering seeking judicial review of NHS England's decision to impose a cap on the number of people treated for

Published
06 June 2016
By
Keith Alcorn
How to meet the first-ever global hepatitis targets

It will be critical to ensure that the ambitious targets towards HCV elimination by 2030 are accompanied by predictable and focussed funding for testing, prevention and treatment, especially for middle-income countries, which suffer from the highest burden of HCV infections. In addition, placing the most at risk populations, in particular PWID, at the centre of the response will be essential. Despite dramatic advances in science with new medicines able to cure nearly all PLHCV, including people co-infected with HIV and the emergence of promising policies, the question of access to care by the communities most in need remains.

Published
06 June 2016
From
International AIDS Society
Indian hepatitis C drug patent decision shakes public health community

On May 9, 2016, the Indian Patent Office granted the US pharmaceutical company Gilead a patent for sofosbuvir, a direct-acting antiviral for the treatment of hepatitis C virus (HCV). The decision to grant the patent reversed an earlier decision by the Indian Patent Office to reject the application after civil society organisations and generic manufacturers had filed a formal opposition to the patent application.

Published
06 June 2016
From
EATG / The Lancet
France to provide universal access to hepatitis C treatment

France will provide access to hepatitis C treatment with direct-acting antivirals to everyone diagnosed with hepatitis C from September 2016, and will begin to provide treatment to

Published
02 June 2016
By
Keith Alcorn
Patients who pay £1,000 for life-saving drugs online that would cost NHS £35,000: More and more are doing it - but doctors warn it's a big risk

Doctors predict that internet drug buyers' clubs are the shape of things to come. Graham Cooke, a consultant in infectious diseases at Imperial College London, says he is supervising NHS patients who have received hep C treatments via fixhepc.com. 'This is a growing trend, as the prices for cancer drugs and other treatments mean they are increasingly unavailable on the NHS,' he adds.

Published
01 June 2016
From
Daily Mail
Burden of pricey hepatitis C drugs heaviest in eastern Europe

New hepatitis C drugs that can cure the liver-destroying disease are revolutionizing treatment but their high price is a huge burden in some countries, particularly in central and eastern Europe, according to a new study.

Published
01 June 2016
From
Reuters

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close